First quarter and AGM commentary confirm a strong start to FY21, and we lift our full year EBITDA forecast to $6.6M. Prior investment in plant and people is beginning to deliver results, with a sales and marketing team leveraging efficient production of a broader product range to land it on shelves and in venues. Our target price lifts to $0.080 (prior $0.075), we expect a good half year result to be reported, and we maintain a BUY call.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.